Sanofi (SNY) to Stop Research in Diabetes, Cardiovascular Diseases, May Sell Regeneron (REGN) Stake - Reports
Tweet
Share
E-mail
Get Alerts SNY Hot Sheet
Join SI Premium – FREE
Sanofi (NASDAQ: SNY) to Stop Research in Diabetes, Cardiovascular Diseases, May Sell Regeneron (NASDAQ: REGN) Stake - Reports
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sanofi (SNY) call put ratio 8.4 calls to 1 put with a focus on July 45 calls
- Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma
- Sinda Ltd. files for IPO on NYSE, targeting up to $13.25 per share
Create E-mail Alert Related Categories
Corporate News, Hot Corp. NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
